Status:
COMPLETED
Interdisciplinary Case-Control Study of Non-Hodgkin's Lymphoma
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Non-Hodgkin's Lymphoma
Eligibility:
All Genders
20-74 years
Brief Summary
Non-Hodgkin's lymphoma (NHL) incidence rates have risen three percent per year in the U.S. for four decades. Mortality from NHL has risen 1.6 percent, compared with 0.2 percent for all cancers combine...
Detailed Description
Non-Hodgkin's lymphoma (NHL) incidence rates have risen three percent per year in the U.S. for four decades. Mortality from NHL has risen 1.6 percent, compared with 0.2 percent for all cancers combine...
Eligibility Criteria
Inclusion
- ELIGIBILITY CRITERIA:
- Women and men residing in the areas served by the four SEER registries.
- Individuals between the ages of 20 and 74 (ages between 20 and 64 must live in households with telephones).
- Individuals who have a first primary diagnosis of NHL after April 1, 1998 to July 1, 1998.
- Individuals must be HIV negative.
- EXCLUSION CRITERIA:
- Individuals must not be previously diagnosed with NHL.
Exclusion
Key Trial Info
Start Date :
April 15 1998
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 17 2007
Estimated Enrollment :
2378 Patients enrolled
Trial Details
Trial ID
NCT00341952
Start Date
April 15 1998
End Date
April 17 2007
Last Update
November 27 2020
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Southern California
Los Angeles, California, United States, 90033
2
University of Iowa
Iowa City, Iowa, United States, 52242
3
Wayne State University Hutzel Hospital
Detroit, Michigan, United States, 48201
4
University of Washington
Seattle, Washington, United States, 98195